AU768399B2 - Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use - Google Patents
Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use Download PDFInfo
- Publication number
- AU768399B2 AU768399B2 AU39611/00A AU3961100A AU768399B2 AU 768399 B2 AU768399 B2 AU 768399B2 AU 39611/00 A AU39611/00 A AU 39611/00A AU 3961100 A AU3961100 A AU 3961100A AU 768399 B2 AU768399 B2 AU 768399B2
- Authority
- AU
- Australia
- Prior art keywords
- micromixer
- communicating channel
- mixed
- preparation
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000002537 cosmetic Substances 0.000 title claims description 21
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 38
- 230000008569 process Effects 0.000 claims description 37
- 239000000839 emulsion Substances 0.000 claims description 34
- 238000002360 preparation method Methods 0.000 claims description 33
- 238000002156 mixing Methods 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 26
- 238000009472 formulation Methods 0.000 claims description 23
- 230000015572 biosynthetic process Effects 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 8
- 239000002502 liposome Substances 0.000 claims description 8
- 238000005086 pumping Methods 0.000 claims description 8
- 238000010792 warming Methods 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 4
- 239000000306 component Substances 0.000 claims 18
- 239000012071 phase Substances 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 239000004480 active ingredient Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 239000000654 additive Substances 0.000 description 10
- 239000004530 micro-emulsion Substances 0.000 description 10
- 239000000499 gel Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 238000003756 stirring Methods 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 238000000265 homogenisation Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 230000037072 sun protection Effects 0.000 description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 3
- 239000002612 dispersion medium Substances 0.000 description 3
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 3
- 229960000655 ensulizole Drugs 0.000 description 3
- -1 for example Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229960003415 propylparaben Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- JKXYOQDLERSFPT-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO JKXYOQDLERSFPT-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 229920004511 Dow Corning® 200 Fluid Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000004907 Macro-emulsion Substances 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- WTHDKMILWLGDKL-UHFFFAOYSA-N urea;hydrate Chemical compound O.NC(N)=O WTHDKMILWLGDKL-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/066—Multiple emulsions, e.g. water-in-oil-in-water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
- B01F2101/21—Mixing of ingredients for cosmetic or perfume compositions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
- B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
2001 9911777.doc 1/22 -1- Process for the preparation of cosmetic or pharmaceutical formulations using a micromixer The present invention relates to a process for the preparation of cosmetic or pharmaceutical formulations immediately before use, in which two or more liquid components from separate stock chambers are mixed intimately with one another by passing the liquid components through a micromixer. The present invention furthermore relates to the lotions, emulsions, gels, creams and solutions prepared by the process according to the invention, either for cosmetic use or, if corresponding pharmaceutical active ingredients have been incorporated, to the pharmaceutical formulations prepared.
15 Various processes for mixing a plurality of substances as intimately as possible are used for the preparation of cosmetic products. Depending on the mixing intensity necessary, use is made of one or more processes for combining substances, which can take place successively or in parallel.
In chemical process technology, the term mixing is taken to mean per se basic operations which serve for very substantial homogenisation of substances. The aim is to combine substance streams in such a way that the most uniform composition possible of the individual components is obtained in part-volumes of the resultant mixture.
A special form of mixing is homogenisation. This is taken to mean mixing of phases which are immiscible with one another. Accordingly, the term homogenisation is taken to mean a change in the state of distribution and the particle size of the internal phase of emulsions and suspensions, so that, in microscopic terms, a homogenous system is formed and the distributed phase does not settle out or cream up without the action of external forces.
The term dispersion is taken to mean mixing of a substance system consisting of two (or more) phases, in which one substance (disperse phases) is distributed (dispersed) in extremely fine form in another substance (dispersion medium). Both the particles of the disperse phase 2001 9911777.doc 2/22 -2and the dispersion medium may be solid, liquid or gaseous. Examples of dispersions are aerosols, emulsions, suspensions and colloids.
Another type of mixing which is conventional in the preparation of cosmetics is emulsification. This is taken to mean mixing of two liquids which are insoluble or only sparingly soluble in one another and of which one is finely distributed in the other. The external phase is referred to as the continuous phase or dispersion medium, and the liquid distributed therein is referred to as the internal, discontinuous or disperse phase.
Cosmetic emulsions usually consist of an aqueous polar phase and a nonpolar oil phase.
The term suspension on the other hand is taken to mean the distribution of very small, but not molecular particles of a solid in a liquid. Suspensions, like emulsions, are usually optically cloudy and tend to settle out under the influence of gravity.
Emulsification processes are usually carried out in accordance with the following scheme: two substances which are insoluble in one another, namely fat and water, are mixed. In order to obtain a durable emulsion, the fat and water phases must be comminuted mechanically to less than pm and subsequently stabilised with the aid of an emulsifier. The oil and fat phase are normally initially introduced separately, warmed to 0 C and subsequently pre-emulsified. All water-soluble substances are located in the water phase, and all fat-soluble substances in the fat phase.
The pre-emulsion prepared by the hot/hot process (both phases are warmed separately to 50-70 0 C) is cooled to room temperature before addition of perfume oil and dye and is subsequently post-emulsified.
Some cases of emulsion preparation can start from a water phase at 20 30 0 C. In this hot/cold process, cooling before addition of perfume oil and dye can be omitted.
If the fat phase here is an oil which has low viscosity at room temperature, both phases can be initially introduced and emulsified at a temperature of 20-30 0 C (cold/cold process) (from W. Umbach, "Kosmetik" [Cosmetics], Georg Thieme Verlag, Stuttgart, 1995).
9911777.doc 3/22 -3- In the preparation of emulsions, suspensions and dispersions which are delivered to the end consumer, it is desirable to obtain products which are stable for an extended period, do not tend to separate out and in which at the same time the added active ingredients retain their activity;The stability of mixtures is achieved in conventional products by the addition of additives, such as, for example, emulsifiers, surfactants or the like. In order to prevent decomposition of the contents and to hinder a decrease in the activity of active ingredients present, oxidation stabilisers, freeradical scavengers, bactericides and other additives, for example, are added. Various of these additives may result in irritation or allergies in the case of sensitive users.
In order to stabilise active ingredients, it is in many cases not the active ingredient itself that is used, but instead one of its more stable derivatives, which then decomposes at the site of action and liberates the active ingredient. This is of course afflicted with the problem that the derivative behaves differently to the actual active ingredient in any prior transport or metabolism processes which are necessary.
A further problem in the preparation of the above-mentioned mixtures is homogeneous mixing of the individual substances in each volume element of the mixture as a whole.
r In order to prepare cosmetic formulations, simple stirred vessels with various types of stirrer are frequently used. Depending on the stirrer type (for example anchor, propeller, inclined-blade, disc, EKATO multistage 25 impulse countercurrent stirrers or EKATO Mizer disc), different shear forces occur in the stirred vessels depending on the location in the stirred vessel. The same applies to the temperature distribution and energy input into the formulation, which means that shear forces, temperature and introduced energy are not "uniformly" distributed in the batch vessel, and 30 consequently the build-up of the resultant formulation is adversely affected. In concrete terms, this means that, for example, emulsions may form in which the emulsified phase has very different particle sizes, or the active-ingredient distribution in a prepared product is non-uniform.
The present invention therefore seeks to provide a process which gives mixed products which have a homogeneous distribution of all 9911777.doc 4/22 -4components in the mixture as a whole and at the same time have a homogeneous distribution of the particle or droplet size. A further object of the invention is to provide a process for the preparation of cosmetic or pharmaceutical formulations by means of which the use of emulsifiers, surfactants, stabilisers, oxidation stabilisers, free-radical scavengers, bactericides and other additives can be restricted or by means of which, in the ideal case, their use can be omitted entirely. A further object of the invention is to provide a process by means of which cosmetic or pharmaceutical formulations can be prepared in very small amounts immediately before their use.
This outcome sought by a process for the preparation of cosmetic or pharmaceutical formulations immediately before use, characterised in that two or more liquid components from separate stock chambers are mixed with one another by passing them through a micromixer.
In order to carry out the process according to the invention, two or more components in liquid form, if necessary after warming, from separate stock chambers are passed through a micromixer for mixing.
The mixing can take place by passing the components in liquid form, if necessary after warming, from separate stock chambers through a temperature-controlled micromixer and if necessary continuing stirring for 25 cooling.
The process for the preparation of cosmetic or pharmaceutical formulations in the form of emulsions immediately before use can be carried out by passing one or more liquid component(s) with one or more natural, synthetic or semi-synthetic oil(s) from separate stock chambers through a micromixer, during which they are mixed with one another.
eeoc The invention's desired outcome is also sought by a process for the preparation of cosmetic formulations in the form of emulsions immediately before use, characterised in that a fat phase consisting of one or more natural, synthetic or semi-synthetic oil(s) and one or more fat(s) which is 2001 9911777.doc 5/22 1 (are) solid at room temperature, is liquefied in a stock chamber by warming, and this liquid fat phase is mixed with one or more liquid component(s) and optionally with a further oil phase by passing them through a micromixer.
In a particular embodiment of the process according to the invention, the components to be mixed are pumped from the stock chambers into a micromixer through connecting thin tubes, each of which terminates in a channel of the micromixer, and is forced through the channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of an emulsion.
It is also possible in accordance with the invention to convey the components to be mixed from pressurised stock chambers through connecting thin tubes, each of which terminates in a channel of a micromixer, to feed the components into the micromixer and to force them through the channels of the micromixer due to the pressure which builds up, with intensive mixing and formation of an emulsion.
The invention's desired outcome is furthermore sought by a process for the preparation of liposome-containing formulations immediately before use by mixing one or more liquid component(s) with a component which contains liposome-forming contents from separate stock chambers with one another by passing them through a micromixer with formation of the desired liposomes. This can be carried out after one or more of the component(s) to be mixed has (have) been warmed before preparation of the formulation.
This process can be carried out by pumping the components to be mixed from the stock chambers and feeding them into a micromixer through connecting thin tubes, each of which terminates in a channel of the micromixer, and forcing them through the channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of a liposome-containing formulation.
In particular, the components to be mixed can be conveyed from 35 pressurised stock chambers and fed into a micromixer through connecting thin tubes, each of which terminates in a channel of the micromixer. Owing 2001 9911777.doc 6/22 -6to the pressure prevailing in the stock chambers, an adequate pressure is built up in the micromixer to force the components through the channels with intensive mixing and formation of a liposome-containing formulation.
The present invention is also achieved by means of lotions or solution, emulsions, gels and creams which can be prepared by the process according to the invention.
For certain formulations, uniform mixing, a constant temperature and uniform input of energy even at the micro-level, are important.
It has now been found that the use of micromixers enables the preparation of mixtures in the form of emulsions, suspensions and dispersions, lotions, solutions gels and creams in which all contents are uniformly distributed, even in extremely small volume parts. In contrast to a large-volume stirred reactor, it is possible to prepare these mixtures under uniform temperature conditions, even at the micro-level, since no temperature gradient forms in the thin, optionally laminate-like channels, in particular if the micromixer has a temperature-controllable design. Furthermore, the input of energy is the same in each volume part, i.e. even in the smallest. It has also been found that emulsions having a significantly more homogeneous droplet size distribution can be prepared than in a stirred vessel. Owing to the multiple shear conditions of the communicating channels in the micromixer, droplet sizes in the micro-range are inevitably specified, so that microemulsions are obtained, which could only be prepared in a very complex manner in a stirred vessel. The use of a micromixer is therefore suitable for the preparation of very fine homogeneous formulations.
Suitable for carrying out the process according to the invention are micromixers and associated connection and sealing systems which are described in the patent applications DE 1 95 11 603, DE 1 97 46 583, DE 1 97 46 584, DE 19746585 and DE 1 98 54 096, and modifications thereof that are evident to the person skilled in the art. Suitable micromixers may consist of suitable metallic, ceramic or polymeric materials or of silicon.
Problematic formulations in the W/O area are emulsions, in particular those having high contents of vegetable triglycerides. Emulsions without 2001 9911777.doc 7/22 -7stabilising waxes are frequently distinguished by inadequate long-term viscosity constancy, and O/W lotions are generally more difficult to stabilise than creams. These emulsions can therefore be prepared particularly well using micromixers. It is of particular advantage here than the use of micromixers enables particularly small amounts to be prepared, which can advantageously be prepared in situ, i.e. directly before use.
Microemulsions are thermodynamically stable if, owing to extremely low interfacial energy, they are formed spontaneously, i.e. without the supply of external mechanical energy. The droplet diameters are significantly smaller than in the case of macroemulsions; they are in the range nm (nanometers), i.e. below the wavelength of visible light. Microemulsions are therefore colloidally disperse, optically transparent systems. According to POHLER, certain concentration ranges of the oil and water phases and of the emulsifiers and auxiliaries must be observed for the formulation of microemulsions: Surfactants (usually nonionic surfactants) 15 Mineral oil or vegetable oil 5 Polyalcohols 0- Water 35 The use of micromixers for the preparation of microemulsions enables the use of surfactants to be considerably reduced, enabling the toleration for particularly sensitive skin types to be significantly increased. Stable microemulsions can be prepared using as little as less than 10% by weight of surfactants.
The most important requirements of emulsification equipment are usually adequate and in particular variable emulsification power, sufficient shear or impact forces, fitting-out for uniform treatment of the batch, vacuum device, heating and cooling These problems can be solved in a simple manner in accordance with the invention through the use of a suitable micromixers, which ensure specific input of energy in each 2001 9911777.doc 8/22 -8volume element and in which intensive mixing takes place in the thin channels with exposure to intensive shear forces.
The use of micromixers furthermore enables very small amounts of the desired cosmetic or pharmaceutical formulations to be prepared immediately before use. This has the advantage that the addition of emulsifiers, suspension aids and dispersion aids in the form of surfactants and other additives, such as, for example, stabilisers, can be greatly restricted or their use can be omitted entirely. It is also possible in this way for active ingredients or additives which are incompatible with one another in a formulation over an extended period not to be mixed with one another until directly before use.
Active ingredients which are only stable in a formulation in the form of a derivative can be initially introduced as such in a separate formulation and not added to the remaining mixture until directly before use. This also enables the user to add various additives, as desired, to small amounts of a base mixture at various points in time. This may be of interest both for pharmaceutical and for cosmetic formulations if different active ingredients are to be applied at different points in time.
Different additives can be added to a cosmetic base formulation for the day than for the night. Additives for the day may be, for example, UV filters, while those for the night may be regenerating additives.
For better understanding and for illustration, examples are given below which fall within the scope of protection of the present invention, but are not suitable for restricting the invention to these examples.
Example 1 Hand and nail cream Raw material INCI
WW
A Paraffin Mineral Oil 2.00 (Art. No. 107162) Arlamol HD Isohexadecane 2.00 2001 9911777.doc 9/22 -9- Isopropyl palmitate Soya oil Mirasil DM 350 Lanette O Span 60 Montanov 68 -(a-Bisabolol (Art. No.130170) Isopropyl Palmitate Glycine Soya Dimethicone Cetearyl Alcohol Sorbitan Stearate Cetearyl Alcohol (and) Cetearyl Glucoside Bisabolol Aqua Glycerin Panthenol Biotin 3.00 0.50 1.00 1.00 1.50 4.00 0.30 B Demin. water Glycerin, 87% (1) (Art. No.104091) D-Panthenol (7) (D+)-Biotin (1) (Art. No.130220) (if desired) preservatives to 100 10.00 0.50 0.05 q.s.
C Rhodicare S If desired: D Perfume Bianca Xanthan Gum 0.30 Perfume 0.20 Preparation: Phases A, B and C are each introduced separately into a stock container and heated to 75 0 C. The consequently liquid phases B and C are pumped out of the stock containers and passed through a micromixer held at 75°C and mixed. The mixture emerging from the micromixer is subsequently pumped with phase A through a micromixer held at 75C and homogenised. The resultant emulsion is collected in a stock container and cooled with stirring. At a temperature of about 0 C, the perfume can be added if desired.
Notes: pH 25 oc value: Viscosity: 43000 mPa.s (Brookfield RVT, spindle C, 5 rpm, Helipath) at 25 0
C
0.05% of propyl 4-hydroxybenzoate (Merck KGaA, Art. No. 130173), 2001 9911777.doe 10/22 0. 15% of methyl 4-hydroxybenzoate (Merck KGaA, Art. No. 13 0174), 0.30% of Germall 115 (ISP, Frechen) Procurement sources: Merck KGaA, Darmstadt ICI Surfactants, Essen Henkel KGaA, D~sseldorf Gustav Hees, Stuttgart Rhodia, Frankfurt Seppic, France BASF, Ludwigshafen HandR, Holzminden 2001 9911777.doc 11/22 11 Example 2 W/0 body-care milk (COLD PREPARATION) A. ARLACEL 780 5.0 Paraffin oil, low-viscosity 10.0% Miglyol 812 4.0 ARLAMOL HD 50 ARLAMOL E Perfume (if desired) q.s.
B. Glycerin ATLAS G-2330 Mg S0 4 0.5 Demin. water 70.5 Preservative (if desired) q.s.
Preparation method: The two phases A and B are each introduced separately into a stock container. After mixing, which can be carried out either by stirring or in small vessels by shaking, the phases are pumped out of the stock containers and passed jointly through a micromixer, in which the phases are mixed intensively. The homogeneously mixed milk can be used directly.
Viscosity: 000 mPa s (Brookfield LVT Helipath, spindle C, 6 rpm, 1 min.) Procurement sources: ICI Surfactants Example 3 Sun-protection milk (water in silicone) 2001 9911777.doc 12/22 12- A Eusolex 2292 (Art. No. 5382) DC 1401 DC 3225 C Dow Corning 344 B Eusolex 232 (Art. No. 5372) aminomethane (Art. No. 8386) No. 6400) 2.00 10.00 10.00 10.00 q.s.
2.00 Tris(hydroxymethyl)- 0.88 Sodium chloride (Art.
2.00 Glycerin (Art.-Nr. 4093) 5.00 Preservative (if q.s.
Water, to 100.00 desired.) demineralised Preparation: In order to prepare phase B, tris(hydroxymethyl)aminomethane for neutralisation of Eusolex 232 is dissolved in water in a stock vessel, and Eusolex 232 is added. After complete dissolution, the remaining raw materials of phase B are added. The components of phase A are premixed in a second stock vessel.
In order to prepare the sun-protection milk, the two phases are, for mixing, pumped jointly with the aid of a pump through a micromixer connected via thin connecting tubes.
Notes Viscosity 22,800 mPas (Brookfield RVT, spindle C, 10 rpm) at 25 'C Samples contain the following as preservatives: 0.05% of propyl 4-hydroxybenzoate (Merck Art. No. 7427) 0.17 of methyl 4-hydroxybenzoate, sodium salt (Merck Art. No. 6756) 2001 9911777.doc 13/22 -13- Procurement sources: E. Merck, Darmstadt Dow Corning, Dusseldorf Example 4 Transparent microemulsion Trade name Eumulgin B2 Cetiol RE Uniphen P-23 Mineral oil Glycerin Water, demin..
Preparation: INCI by weight Ceteareth-20 PEG-7 Glyceryl Cocoate Phenoxyethanol Methyl-/ Ethyl-/Propyl-/Butylparaben Mineral Oil Glycerin Water 19.5 20.0 0.3 20.0 35.2 1. Eumulgin B2, Cetiol HE, Uniphen P-23 and the paraffin oil are introduced into a stock vessel, melted with mixing and heated to about 95C-1050C.
2. Water and the glycerin are combined and likewise heated to about 95 0 C-100 0 C. Increase the amount of water by 3%.
3. The water phase and the fat phase are pumped through a micromixer for intensive mixing. The resultant microemulsion gel stirs for cooling.
Alternatively, it is possible to pass the microemulsion gel through a further, cooled micromixer whose exit channels have a broader cross section, thus preventing blockage of the channels and suppressing the formation of air bubbles in the gel.
At a temperature at which the microemulsion gel is still just pourable, it is transferred into the primary packaging.
2001 9911777.doc 14/22 -14- Example Sun-protection gel (emulsifier-free) SPF 3.21 UVA PF 2.5 (sun protection factor, Diffey Method) by weight A Eusolex 2292 (Art. No. 105382) 1.000 Luvitol EHO 9.000 Dow Corning 200 (100 cs) 2.000 Antaron V-220 2.000 Jojoba oil 5.000 DL-a-Tocopherol acetate 0.500 (Art. No. 500952) B Tris(hydroxymethyl)aminomethane 0.700 (Art. No. 108386) Water, demineralised 14.300 C Pemulen TR-1 0.600 Preservative (if desired) q.s.
Water, demineralised to 100. 000 D Aloe Vera Gel 1: 10 1.000 Preparation: For phase C, homogeneously disperse the Pemulen TR-1 in water, add preservative and pre-swell. Introduce phase B into phase C with homogenisation. Dissolve phase A with heating and add slowly with homogenisation. Add phase D at 35°C and again homogenise.
Notes: Viscosity 67,000 mPas (Brookfield RVT, spindle C, 5 rpm) at
PH
25 oc 6.9 As preservative, 1.0% of phenoxyethanol (Merck Art. No. 807291) can be i1 added.
2001 9911777.doc 15/22 Procurement sources (1) (3) (5) (7) Merck KGaA, Darmstadt Dow Corning, Dusseldorf Henry Lamnotte, Bremen Rahn, Maintal BASF, Ludwigshafen GAF, Frechen Goodrich, Neuss Example 6 In situ W/O/Wsuper-moisturising cream Composition:
WIW
'Brij 721 Brij 72 Arlacel P135 Arlamol E Arlamol
HD
Vitamin E acetate Laurex CS Stearic acid Mirasil DM 100 1.2-Propylene glycol Allantoin Urea Water 0.2 74.4 Germaben 111.
2001 9911777.doc 16/22 -16- D. (if desired) Perfume L94-5770 0.1 Preparation: 1. A and B are warmed to a temperature of 75 0 C in separate stock containers.
2. Before the emulsion is prepared, C is added to B.
3. The phases A and B/C are mixed intensively by pumping them through a micromixer held at 75 0
C.
4. The resultant emulsion is collected in a stock vessel.
5. If desired, D is added after cooling to a temperature below 35 0
C.
6. Further cooling to room temperature is carried out with gentle stirring.
Notes: Viscosity 43,000 mPa.s (Brookfield LVT T-bar spindle, E, rpm 6, 1 min.) Example 7 W/ONW face moisturiser (two-step preparation) Composition: Primary emulsion W/O
W/W
A. Arlacel 1MO 3.3 Arlacel 2064 Arlamol HD 15.0 Arlamol' M812 14.0 B Water 63.7 Germaben II 2001 9911777.doc 17/22 -17- Secondary emulsion W/O/W A. Primary emulsion W/O 50.0 B. 'Arlatone 2121 Water 44.1 Keltrol 0.4 C. Germaben II Preparation: Primary emulsion W/O 1. B is slowly added to A with vigorous stirring.
2. The resultant emulsion is homogenised for a further 5 minutes.
Secondary emulsion W/O/W 1. The composition indicated under B with the exception of Keltrol is warmed to a temperature of 80 0 C. Keltrol is dispersed in the initially introduced composition with stirring at constant temperature.
The two separately prepared compositions A and B are mixed in a micromixer as described above.
2. C is added to the emulsion cooled to a temperature below 40 0
C.
25 3. The mixture is cooled to room temperature with gentle stirring..
Notes:: Viscosity 16,000 mPa.s (Brookfield LVT, spindle D, rpm 6, min.) Persons skilled in the art will appreciate that numerous variations and modifications will become apparent. All such variations and modifications which become apparent to persons skilled in the art, should be considered to fall within the spirit and scope that the invention broadly appearing 35 before described.
*o* PAWPDOCS\CRN\Susn\Spc\7631680.doc-02/UI03 -17a- Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or group of integers or steps but not the exclusion of any other integer or group of integers or steps.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgement or any form of suggestion that the prior art forms part of the common general knowledge in Australia.
**o *e
Claims (16)
1. Process for the preparation of cosmetic and/or pharmaceutical formulations immediately before use, characterised in that two or more liquid components from separate stock chambers are mixed with one another by passing them through a communciating channel within a micromixer, wherein the liquid components are exposed to multiple shear conditions within the communicating channel of the micromixer.
2. Process for the preparation of cosmetic and/or pharmaceutical formulations, characterised in that, characterised in that two or more components in liquid form, if necessary after warming, from separate stock chambers are passed through a communicating channel within a micromixer for mixing, wherein the liquid components are exposed to multiple shear conditions within the communicating channel of the micromixer.
3. Process according to Claims 1 to 2, characterised in that two or more components in liquid form, if necessary after warming, from separate 20 stock chambers are passed through a communicating channel within a temperature-controlled micromixer for mixing, wherein the liquid :components are exposed to multiple shear conditions within the communicating channel of the micromixer and subsequently stirred.
4. Process for the preparation of cosmetic and/or pharmaceutical formulations in the form of emulsions immediately before use, characterised in that one or more liquid component(s) with one or more natural, synthetic or semi-synthetic oil(s) from separate stock chambers are mixed with one another by passing them through a communicating channel within a micromixer, wherein the liquid components are exposed to multiple shear conditions within the communicating channel of the micromixer.
Process for the preparation of cosmetic and/or pharmaceutical formulations in the form of emulsions immediately before use, characterised in that a fat phase consisting of one or more natural, P:\WPDOCS\CRNSum\Sp\763 16S0.doc-02/03 -19- solid at room temperature, is liquefied in a stock chamber by warming, and this liquid fat phase is mixed with one or more liquid component(s) and, if desired, with a further oil phase by passing them through a communicating channel within a micromixer, wherein the liquid components are exposed to multiple shear conditions within the communicating channel of the micromixer.
6. Process according to Claims 1 to 5, characterised in that the com- ponents to be mixed are pumped from the stock chambers and fed into a micromixer through connecting thin tubes, each of which terminates in a communicating channel of the micromixer, and forced through the communicating channels of the micromixer owing to the pressure building up due to the pumping, with intensive mixing and formation of an emulsion.
7. Process according to Claims 1, 4 to 6, characterised in that the com- ponents to be mixed are pumped from the pressurised stock cham- bers, fed into a micromixer through connecting thin tubes, each of which terminates in a communicating channel of the micromixer, and forced through the communicating channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of an emulsion.
8. Process for the preparation of liposome-containing formulations immediately before use, characterised in that one or more liquid com- ponent(s) with a component containing liposome-forming contents from separate stock chambers are mixed with one another by passing them through a communicating channel within a micromixer with formation of the desired liposomes, wherein the liquid components 30 are exposed to multiple shear conditions within the communicating channel of the micromixer.
9. Process for the preparation of liposome-containing formulations according to Claim 8, characterised in that one or more of the com- ponent(s) to be mixed is (are) warmed before preparation of the formulation.
P:\WPDOCS\CR Susm\Spm\761680.dc.O02IO1O3 Process according to Claims 8 to 9, characterised in that characterised in that the components to be mixed are pumped from the stock chambers and fed into a micromixer through connecting thin tubes, each of which terminates in a communicating channel of the micromixer, and forced through the communicating channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of a liposome- containing formulation.
11. Process according to Claims 8 to 10, characterised in that the com- ponents to be mixed are pumped from pressurised stock chambers and fed into a micromixer through connecting thin tubes, each of which terminates in a communicating channel of the micromixer, and forced through the communicating channels of the micromixer owing to the pressure which builds up due to the pumping, with intensive mixing and formation of a liposome-containing formulation.
12. Lotion or solution, prepared by a process according to Claims 1 to 11.
:13. Emulsion, prepared by a process according to Claims 1 to 11.
14. Gel, prepared by a process according to Claims 1 to 11.
15. Cream, prepared by a process according to Claims 1 to 11.
16. Process for the preparation of cosmetic and/or pharmaceutical formulations, and/or the formulations prepared thereby, substantially as hereinbefore described, with reference to the accompanying 30 Examples. DATED this 2nd day of October, 2003 MERCK PATENT GMBH by its Patent Attorneys DAVIES COLLISON CAVE
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19911777A DE19911777A1 (en) | 1999-03-17 | 1999-03-17 | Process for the preparation of cosmetic formulations |
| DE19911777 | 1999-03-17 | ||
| PCT/EP2000/001974 WO2000054735A1 (en) | 1999-03-17 | 2000-03-07 | Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3961100A AU3961100A (en) | 2000-10-04 |
| AU768399B2 true AU768399B2 (en) | 2003-12-11 |
Family
ID=7901216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU39611/00A Ceased AU768399B2 (en) | 1999-03-17 | 2000-03-07 | Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1161221A1 (en) |
| JP (1) | JP2002538947A (en) |
| CN (1) | CN1344145A (en) |
| AU (1) | AU768399B2 (en) |
| CA (1) | CA2367391A1 (en) |
| DE (1) | DE19911777A1 (en) |
| WO (1) | WO2000054735A1 (en) |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9017623B2 (en) | 2007-02-06 | 2015-04-28 | Raindance Technologies, Inc. | Manipulation of fluids and reactions in microfluidic systems |
| US9328344B2 (en) | 2006-01-11 | 2016-05-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US10357772B2 (en) | 2007-04-19 | 2019-07-23 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US10639597B2 (en) | 2006-05-11 | 2020-05-05 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
| US10732649B2 (en) | 2004-07-02 | 2020-08-04 | The University Of Chicago | Microfluidic system |
| US11077415B2 (en) | 2011-02-11 | 2021-08-03 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
| US11168353B2 (en) | 2011-02-18 | 2021-11-09 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US11187702B2 (en) | 2003-03-14 | 2021-11-30 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US11254968B2 (en) | 2010-02-12 | 2022-02-22 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11390917B2 (en) | 2010-02-12 | 2022-07-19 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US11635427B2 (en) | 2010-09-30 | 2023-04-25 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
| US11786872B2 (en) | 2004-10-08 | 2023-10-17 | United Kingdom Research And Innovation | Vitro evolution in microfluidic systems |
| US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US12097475B2 (en) | 2004-07-02 | 2024-09-24 | The University Of Chicago | Microfluidic system |
| US12352673B2 (en) | 2009-03-23 | 2025-07-08 | Bio-Rad Laboratories, Inc. | Manipulation of microfluidic droplets |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8328829B2 (en) | 1999-08-19 | 2012-12-11 | Covidien Lp | High capacity debulking catheter with razor edge cutting window |
| US6299622B1 (en) | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
| US7708749B2 (en) | 2000-12-20 | 2010-05-04 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
| US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
| ATE499054T1 (en) | 2000-12-20 | 2011-03-15 | Fox Hollow Technologies Inc | REDUCTION CATHETER |
| DE10100721A1 (en) * | 2001-01-10 | 2002-07-11 | Beiersdorf Ag | Stable, aqueous UV-protective cosmetic or dermatological preparation, contains benzimidazole-sulfonic acid derivative UV filter, water-soluble preservative and water-soluble or -dispersible dye |
| DE10208265A1 (en) | 2002-02-26 | 2003-09-11 | Beiersdorf Ag | Continuous production of cosmetic and/or dermatological compositions, containing temperature-sensitive components, comprises emulsification, addition of sensitive components and then homogenization |
| ATE330697T1 (en) * | 2002-04-16 | 2006-07-15 | Fuchs Lubritech Gmbh | METHOD FOR THE PRODUCTION AND APPLICATION OF EMULSIFIER-FREE OIL-IN-WATER DISPERSIONS AS A RELEASE AGENT OR COOLING LUBRICANT |
| DE10219523A1 (en) * | 2002-05-02 | 2003-11-13 | Wella Ag | Process for the technical production of hair or skin cosmetic products using equipment with microstructure units |
| JP2006507921A (en) * | 2002-06-28 | 2006-03-09 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Method and apparatus for fluid dispersion |
| AU2004229440B2 (en) | 2003-04-10 | 2010-08-12 | President And Fellows Of Harvard College | Formation and control of fluidic species |
| US8246640B2 (en) | 2003-04-22 | 2012-08-21 | Tyco Healthcare Group Lp | Methods and devices for cutting tissue at a vascular location |
| DE10333924B3 (en) * | 2003-07-25 | 2004-10-07 | Wella Ag | Packaging system for multicomponent products (e.g. cosmetics or pharmaceuticals) requiring mixing immediately before use, comprises assembly of static micro-mixers |
| JP2005068125A (en) * | 2003-08-21 | 2005-03-17 | Rohm & Haas Co | Methods for preparing biocide formulations |
| JP4025735B2 (en) * | 2003-08-21 | 2007-12-26 | ローム アンド ハース カンパニー | Method for treating aqueous systems |
| WO2005021151A1 (en) | 2003-08-27 | 2005-03-10 | President And Fellows Of Harvard College | Electronic control of fluidic species |
| EP1703968A1 (en) * | 2003-12-16 | 2006-09-27 | Unilever Plc | Microfluidic device |
| JP2007152280A (en) * | 2005-12-07 | 2007-06-21 | Kao Corp | Hydrogel particle production method and composite particle production apparatus used therefor |
| US20070276419A1 (en) | 2006-05-26 | 2007-11-29 | Fox Hollow Technologies, Inc. | Methods and devices for rotating an active element and an energy emitter on a catheter |
| DE102007039005A1 (en) * | 2007-08-14 | 2009-02-19 | Beiersdorf Ag | Micro-emulsion, useful as transparent/translucent cosmetic product or in transparent/translucent cosmetic product preparation, and to prepare skin/hair care product, comprises emulsifying agent and/or co-emulsifying agent |
| DE102007039007A1 (en) * | 2007-08-14 | 2009-02-19 | Beiersdorf Ag | Preparation of transparent or translucent emulsion, useful as cosmetic/in cosmetic preparation, and in skin and hair care product to clean the skin and hair, comprises conducting oil phase comprising silicon and water phase by micro-mixer |
| DE102007057131A1 (en) | 2007-11-26 | 2009-05-28 | Beiersdorf Ag | Preparing an emulsion, useful e.g. as sun protection- or make-up-preparation and as repellents to protect against mosquitoes, comprises mixing fat- and water-phase containing a solid material in a micromixer and emulsifying the mixture |
| US8784440B2 (en) | 2008-02-25 | 2014-07-22 | Covidien Lp | Methods and devices for cutting tissue |
| JP5555242B2 (en) | 2008-10-13 | 2014-07-23 | コヴィディエン リミテッド パートナーシップ | Device and method for operating a catheter shaft |
| AU2010241801B2 (en) | 2009-04-29 | 2013-04-11 | Covidien Lp | Methods and devices for cutting and abrading tissue |
| BRPI1010595A2 (en) | 2009-05-14 | 2017-05-16 | Tyco Healthcare | easily cleanable atherectomy catheters and methods for use |
| KR101130932B1 (en) | 2009-11-12 | 2012-03-29 | 곽영열 | Manufacture system for emulsion using an air |
| WO2011068932A1 (en) | 2009-12-02 | 2011-06-09 | Fox Hollow Technologies, Inc. | Methods and devices for cutting tissue |
| RU2520801C2 (en) | 2009-12-11 | 2014-06-27 | ТАЙКО ХЕЛСКЕА ГРУП эЛПи | Device for material removal with improved capture efficiency and methods for using |
| CN102946815B (en) | 2010-06-14 | 2015-07-15 | 科维蒂恩有限合伙公司 | Material removal device |
| DE102010046931A1 (en) * | 2010-09-29 | 2012-03-29 | Sanderstrothmann Gmbh | Process for the preparation of a cosmetic product |
| RU2539720C2 (en) | 2010-10-28 | 2015-01-27 | Ковидиен Лп | Method for material removal and method of use |
| KR101518151B1 (en) | 2010-11-11 | 2015-05-06 | 코비디엔 엘피 | Flexible debulking catheters with imaging and methods of use and manufacture |
| US8992717B2 (en) | 2011-09-01 | 2015-03-31 | Covidien Lp | Catheter with helical drive shaft and methods of manufacture |
| US9532844B2 (en) | 2012-09-13 | 2017-01-03 | Covidien Lp | Cleaning device for medical instrument and method of use |
| US9943329B2 (en) | 2012-11-08 | 2018-04-17 | Covidien Lp | Tissue-removing catheter with rotatable cutter |
| EP2875803A1 (en) * | 2013-11-26 | 2015-05-27 | OTC GmbH | Polyol-in-oil-emulsions for dermal delivery |
| WO2015200702A1 (en) | 2014-06-27 | 2015-12-30 | Covidien Lp | Cleaning device for catheter and catheter including the same |
| US10314667B2 (en) | 2015-03-25 | 2019-06-11 | Covidien Lp | Cleaning device for cleaning medical instrument |
| US10292721B2 (en) | 2015-07-20 | 2019-05-21 | Covidien Lp | Tissue-removing catheter including movable distal tip |
| FR3039396B1 (en) * | 2015-07-28 | 2017-08-11 | Laboratoires M&L | BASE OF CONCENTRATED COSMETIC FORMULATION |
| US10314664B2 (en) | 2015-10-07 | 2019-06-11 | Covidien Lp | Tissue-removing catheter and tissue-removing element with depth stop |
| KR101990967B1 (en) * | 2016-09-30 | 2019-06-20 | (주)아모레퍼시픽 | Manufacturing Apparatus of Cosmetic Composition Comprising Emulsion Substance made in the Instance Emulsification based on Microchannels |
| KR102371209B1 (en) | 2017-03-24 | 2022-03-07 | (주)아모레퍼시픽 | Apparatus for manufacturing cosmetic using instantaneous emulsification and maufacturing method of cosmetic using instantaneous emulsification |
| DE102020214601A1 (en) | 2020-11-19 | 2022-05-19 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Process and device for the production of a liquid containing liposomes and the liquid produced |
| CN115770273A (en) * | 2022-10-10 | 2023-03-10 | 重庆大学附属肿瘤医院 | A kind of traditional Chinese medicine liniment for external use and its preparation method and equipment |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4769321A (en) * | 1979-10-03 | 1988-09-06 | Self Colin H | Assay method and reagent therefor |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405489A (en) * | 1981-01-15 | 1983-09-20 | Carter-Wallace, Inc. | Production of a post-foaming gel and system therefor |
| DE3230289A1 (en) * | 1982-08-14 | 1984-02-16 | Bayer Ag, 5090 Leverkusen | PRODUCTION OF PHARMACEUTICAL OR COSMETIC DISPERSIONS |
| CA1257545A (en) * | 1985-05-23 | 1989-07-18 | Hans A. Schaeffer | Dental composition, method of preparation thereof and container therefor |
| US5593508A (en) * | 1991-02-11 | 1997-01-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Moist, absorbent material for cleaning articles and surfaces |
| EP0564672B2 (en) * | 1992-04-06 | 1999-05-06 | Baxter International Inc. | Aqueous solution for peritoneal dialysis |
| CN1128946A (en) * | 1994-04-20 | 1996-08-14 | 株式会社绿十字 | Containers filled with infusion solutions, infusion solution preparations and vitamin-containing high-calorie infusion solution preparations |
| EP0729746A1 (en) * | 1995-02-28 | 1996-09-04 | Unilever Plc | Vitamin C delivery system |
| DE19511603A1 (en) * | 1995-03-30 | 1996-10-02 | Norbert Dr Ing Schwesinger | Device for mixing small amounts of liquid |
| JP2975943B2 (en) * | 1996-02-20 | 1999-11-10 | 農林水産省食品総合研究所長 | Emulsion manufacturing method and emulsion manufacturing apparatus |
| DE19611270A1 (en) * | 1996-03-22 | 1997-09-25 | Gesim Ges Fuer Silizium Mikros | Micro-mixer for very small volumes of liquids or suspensions |
| DE19746583A1 (en) * | 1997-10-22 | 1999-04-29 | Merck Patent Gmbh | Micro-mixer for liquid, viscous or gaseous phases |
| DE19746584A1 (en) * | 1997-10-22 | 1999-04-29 | Merck Patent Gmbh | Micro-mixer housing |
| DE19746585A1 (en) * | 1997-10-22 | 1999-04-29 | Merck Patent Gmbh | Coupling for micro components with parallel plates |
| DE19854096A1 (en) * | 1998-11-24 | 2000-05-25 | Merck Patent Gmbh | Connection carrier for plate shaped micro-components, comprises at least one carrier rail fixed to a carrier plate, with a slot for a micro-component insert edge. |
-
1999
- 1999-03-17 DE DE19911777A patent/DE19911777A1/en not_active Withdrawn
-
2000
- 2000-03-07 AU AU39611/00A patent/AU768399B2/en not_active Ceased
- 2000-03-07 JP JP2000604813A patent/JP2002538947A/en active Pending
- 2000-03-07 CA CA002367391A patent/CA2367391A1/en not_active Abandoned
- 2000-03-07 EP EP00918767A patent/EP1161221A1/en not_active Ceased
- 2000-03-07 WO PCT/EP2000/001974 patent/WO2000054735A1/en not_active Ceased
- 2000-03-07 CN CN00805116A patent/CN1344145A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4769321A (en) * | 1979-10-03 | 1988-09-06 | Self Colin H | Assay method and reagent therefor |
Cited By (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11187702B2 (en) | 2003-03-14 | 2021-11-30 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US12097475B2 (en) | 2004-07-02 | 2024-09-24 | The University Of Chicago | Microfluidic system |
| US10732649B2 (en) | 2004-07-02 | 2020-08-04 | The University Of Chicago | Microfluidic system |
| US11786872B2 (en) | 2004-10-08 | 2023-10-17 | United Kingdom Research And Innovation | Vitro evolution in microfluidic systems |
| US12146134B2 (en) | 2006-01-11 | 2024-11-19 | Bio-Rad Laboratories, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9328344B2 (en) | 2006-01-11 | 2016-05-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9410151B2 (en) | 2006-01-11 | 2016-08-09 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9534216B2 (en) | 2006-01-11 | 2017-01-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| US11351510B2 (en) | 2006-05-11 | 2022-06-07 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US10639597B2 (en) | 2006-05-11 | 2020-05-05 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US12337287B2 (en) | 2006-05-11 | 2025-06-24 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US12091710B2 (en) | 2006-05-11 | 2024-09-17 | Bio-Rad Laboratories, Inc. | Systems and methods for handling microfluidic droplets |
| US11819849B2 (en) | 2007-02-06 | 2023-11-21 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US10603662B2 (en) | 2007-02-06 | 2020-03-31 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US9017623B2 (en) | 2007-02-06 | 2015-04-28 | Raindance Technologies, Inc. | Manipulation of fluids and reactions in microfluidic systems |
| US10357772B2 (en) | 2007-04-19 | 2019-07-23 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US10960397B2 (en) | 2007-04-19 | 2021-03-30 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US12590508B2 (en) | 2007-04-19 | 2026-03-31 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US11224876B2 (en) | 2007-04-19 | 2022-01-18 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US11618024B2 (en) | 2007-04-19 | 2023-04-04 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US10675626B2 (en) | 2007-04-19 | 2020-06-09 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US11534727B2 (en) | 2008-07-18 | 2022-12-27 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US11596908B2 (en) | 2008-07-18 | 2023-03-07 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US12352673B2 (en) | 2009-03-23 | 2025-07-08 | Bio-Rad Laboratories, Inc. | Manipulation of microfluidic droplets |
| US10808279B2 (en) | 2010-02-12 | 2020-10-20 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11254968B2 (en) | 2010-02-12 | 2022-02-22 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US12454718B2 (en) | 2010-02-12 | 2025-10-28 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US12529097B2 (en) | 2010-02-12 | 2026-01-20 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11390917B2 (en) | 2010-02-12 | 2022-07-19 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11635427B2 (en) | 2010-09-30 | 2023-04-25 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
| US11077415B2 (en) | 2011-02-11 | 2021-08-03 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
| US11965877B2 (en) | 2011-02-18 | 2024-04-23 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11747327B2 (en) | 2011-02-18 | 2023-09-05 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US12461094B2 (en) | 2011-02-18 | 2025-11-04 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US12140591B2 (en) | 2011-02-18 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US12140590B2 (en) | 2011-02-18 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11168353B2 (en) | 2011-02-18 | 2021-11-09 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11768198B2 (en) | 2011-02-18 | 2023-09-26 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11754499B2 (en) | 2011-06-02 | 2023-09-12 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002538947A (en) | 2002-11-19 |
| AU3961100A (en) | 2000-10-04 |
| CA2367391A1 (en) | 2000-09-21 |
| WO2000054735A1 (en) | 2000-09-21 |
| DE19911777A1 (en) | 2000-09-21 |
| CN1344145A (en) | 2002-04-10 |
| EP1161221A1 (en) | 2001-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU768399B2 (en) | Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use | |
| AU760488B2 (en) | Packaging system for cosmetic formulations | |
| KR101472304B1 (en) | Nano emulsion with stable and uniform particle size distribution | |
| JP2007500590A (en) | Microcapsule filled with active ingredient and method for producing the same | |
| CN1845720B (en) | Concentrated and diluted stable oil-in-water emulsion | |
| JPH09507866A (en) | Sprayable composition containing dispersed powder and method of use thereof | |
| JP2003321325A (en) | Process for commercially manufacturing hair or skin cosmetic product using apparatus having micro structural unit | |
| KR102337010B1 (en) | Semi-transparent oil-in-water cosmetic composition with high content of oil stabilized, and preparing method for the same | |
| ES2399426T3 (en) | Biliquid foams, stable dispersions thereof and a corresponding manufacturing process | |
| Chellapa et al. | Nanoemulsion for cosmetic application | |
| KR101837433B1 (en) | Nanoemulsion, preparing method thereof, and cosmetic composition containing the same | |
| WO2017030409A1 (en) | Blue emulsion composition containing lecithin and sodium dilauramidoglutamide lysine | |
| JP4318265B2 (en) | Multi-component packaging with static micromixer | |
| US20070140042A1 (en) | Multicomponent packaging with static micromixer | |
| JPS63126542A (en) | Microemulsion | |
| KR20200049150A (en) | Oil-in-water type cosmetic composition with a low viscosity comprising a high content of oil | |
| JP2003040367A (en) | Discharge products | |
| WO2021014109A1 (en) | Continuous method for nano-emulsification by concentration phase inversion | |
| Patil et al. | AN OVERVIEW ON NANOEMULSION: A NOVEL DRUG DELIVERY SYSTEM | |
| HK1169812A (en) | Emulsifier-free, polymer-stabilized foam formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |